202 related articles for article (PubMed ID: 16502316)
1. The prognostic value of circulating plasma DNA level and its allelic imbalance on chromosome 8p in patients with hepatocellular carcinoma.
Ren N; Qin LX; Tu H; Liu YK; Zhang BH; Tang ZY
J Cancer Res Clin Oncol; 2006 Jun; 132(6):399-407. PubMed ID: 16502316
[TBL] [Abstract][Full Text] [Related]
2. Loss of heterozygosity at D8S298 is a predictor for long-term survival of patients with tumor-node-metastasis stage I of hepatocellular carcinoma.
Pang JZ; Qin LX; Ren N; Hei ZY; Ye QH; Jia WD; Sun BS; Lin GL; Liu DY; Liu YK; Tang ZY
Clin Cancer Res; 2007 Dec; 13(24):7363-9. PubMed ID: 18094418
[TBL] [Abstract][Full Text] [Related]
3. Circulating DNA level is negatively associated with the long-term survival of hepatocellular carcinoma patients.
Ren N; Ye QH; Qin LX; Zhang BH; Liu YK; Tang ZY
World J Gastroenterol; 2006 Jun; 12(24):3911-4. PubMed ID: 16804981
[TBL] [Abstract][Full Text] [Related]
4. Allelic imbalance regions on chromosomes 8p, 17p and 19p related to metastasis of hepatocellular carcinoma: comparison between matched primary and metastatic lesions in 22 patients by genome-wide microsatellite analysis.
Zhang LH; Qin LX; Ma ZC; Ye SL; Liu YK; Ye QH; Wu X; Huang W; Tang ZY
J Cancer Res Clin Oncol; 2003 May; 129(5):279-86. PubMed ID: 12734753
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of allelic imbalance of chromosome arms 7q, 8p, 16q, and 18q in stage T3N0M0 prostate cancer.
Jenkins R; Takahashi S; DeLacey K; Bergstralh E; Lieber M
Genes Chromosomes Cancer; 1998 Feb; 21(2):131-43. PubMed ID: 9491325
[TBL] [Abstract][Full Text] [Related]
6. [Microsatellite alterations of circulating DNA in the plasma of patients with hepatocellular carcinoma].
Pang JZ; Qin LX; Ren N; Ye QH; Ying WD; Liu YK; Tang ZY
Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(24):1662-5. PubMed ID: 16854315
[TBL] [Abstract][Full Text] [Related]
7. Methylation of tissue factor pathway inhibitor 2 as a prognostic biomarker for hepatocellular carcinoma after hepatectomy.
Sun FK; Sun Q; Fan YC; Gao S; Zhao J; Li F; Jia YB; Liu C; Wang LY; Li XY; Ji XF; Wang K
J Gastroenterol Hepatol; 2016 Feb; 31(2):484-92. PubMed ID: 26313014
[TBL] [Abstract][Full Text] [Related]
8. High level of intercellular adhesion molecule-1 affects prognosis of patients with hepatocellular carcinoma.
Zhu PP; Yuan SG; Liao Y; Qin LL; Liao WJ
World J Gastroenterol; 2015 Jun; 21(23):7254-63. PubMed ID: 26109813
[TBL] [Abstract][Full Text] [Related]
9. Chromosomal allelic imbalance evolving from liver cirrhosis to hepatocellular carcinoma.
Yeh SH; Chen PJ; Shau WY; Chen YW; Lee PH; Chen JT; Chen DS
Gastroenterology; 2001 Sep; 121(3):699-709. PubMed ID: 11522754
[TBL] [Abstract][Full Text] [Related]
10. Tumor size of hepatocellular carcinoma in noncirrhotic liver: a controversial predictive factor for outcome after resection.
Truant S; Boleslawski E; Duhamel A; Bouras AF; Louvet A; Febvay C; Leteurtre E; Huet G; Zerbib P; Dharancy S; Hebbar M; Pruvot FR
Eur J Surg Oncol; 2012 Dec; 38(12):1189-96. PubMed ID: 22863304
[TBL] [Abstract][Full Text] [Related]
11. Chromosome 8 allelic loss and the outcome of patients with squamous cell carcinoma of the supraglottic larynx.
Scholnick SB; Haughey BH; Sunwoo JB; el-Mofty SK; Baty JD; Piccirillo JF; Zequeira MR
J Natl Cancer Inst; 1996 Nov; 88(22):1676-82. PubMed ID: 8931613
[TBL] [Abstract][Full Text] [Related]
12. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
13. Validity of plasma macrophage migration inhibitory factor for diagnosis and prognosis of hepatocellular carcinoma.
Zhao YM; Wang L; Dai Z; Wang DD; Hei ZY; Zhang N; Fu XT; Wang XL; Zhang SC; Qin LX; Tang ZY; Zhou J; Fan J
Int J Cancer; 2011 Nov; 129(10):2463-72. PubMed ID: 21213214
[TBL] [Abstract][Full Text] [Related]
14. High preoparative levels of serum periostin are associated with poor prognosis in patients with hepatocellular carcinoma after hepatectomy.
Lv Y; Wang W; Jia WD; Sun QK; Huang M; Zhou HC; Xia HH; Liu WB; Chen H; Sun SN; Xu GL
Eur J Surg Oncol; 2013 Oct; 39(10):1129-35. PubMed ID: 23916473
[TBL] [Abstract][Full Text] [Related]
15. Frequent loss of heterozygosity in two distinct regions, 8p23.1 and 8p22, in hepatocellular carcinoma.
Lu T; Hano H; Meng C; Nagatsuma K; Chiba S; Ikegami M
World J Gastroenterol; 2007 Feb; 13(7):1090-7. PubMed ID: 17373745
[TBL] [Abstract][Full Text] [Related]
16. Circulating cell-free DNA of methylated insulin-like growth factor-binding protein 7 predicts a poor prognosis in hepatitis B virus-associated hepatocellular carcinoma after hepatectomy.
Li F; Qiao CY; Gao S; Fan YC; Chen LY; Wang K
Free Radic Res; 2018 Apr; 52(4):455-464. PubMed ID: 29463155
[TBL] [Abstract][Full Text] [Related]
17. Surgical margin and Gleason score as predictors of postoperative recurrence in prostate cancer with or without chromosome 8p allelic imbalance.
Zhou W; Goodman M; Lyles RH; Lim SD; Williams TY; Rusthoven KE; Mandel JS; Amin MB; Petros JA
Prostate; 2004 Sep; 61(1):81-91. PubMed ID: 15287096
[TBL] [Abstract][Full Text] [Related]
18. Cytokeratin 10 and cytokeratin 19: predictive markers for poor prognosis in hepatocellular carcinoma patients after curative resection.
Yang XR; Xu Y; Shi GM; Fan J; Zhou J; Ji Y; Sun HC; Qiu SJ; Yu B; Gao Q; He YZ; Qin WZ; Chen RX; Yang GH; Wu B; Lu Q; Wu ZQ; Tang ZY
Clin Cancer Res; 2008 Jun; 14(12):3850-9. PubMed ID: 18559605
[TBL] [Abstract][Full Text] [Related]
19. High-density allelotyping of chromosome 8p in hepatocellular carcinoma and clinicopathologic correlation.
Chan KL; Lee JM; Guan XY; Fan ST; Ng IO
Cancer; 2002 Jun; 94(12):3179-85. PubMed ID: 12115350
[TBL] [Abstract][Full Text] [Related]
20. Microsatellite instability and 8p allelic imbalance in stage B2 and C colorectal cancers.
Halling KC; French AJ; McDonnell SK; Burgart LJ; Schaid DJ; Peterson BJ; Moon-Tasson L; Mahoney MR; Sargent DJ; O'Connell MJ; Witzig TE; Farr GH; Goldberg RM; Thibodeau SN
J Natl Cancer Inst; 1999 Aug; 91(15):1295-303. PubMed ID: 10433618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]